ftInvstr

VIVIMEDLAB · Healthcare ₹5.4 -0.18% Mkt Cap ₹45 Cr

VIVIMEDLAB

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹5.4

-0.18% today · 30d -25.52%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for VIVIMEDLAB. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2025-12-31

REVENUE

₹16 Cr

-56.21% YoY

NET PROFIT

₹-17 Cr

OPM

-68.31%

-71.38pp YoY

EPS

₹-0.88

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-14.0% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

VIVIMEDLAB—-8.0

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 5

Valuation — —

Growth MUTED 30

Profitability LOW 5

Technicals WEAK 45

Risk LOW 90

Key Stats

P/B

-0.21

52W HIGH

₹29.4

OFF HIGH

-81.63%

DIV YIELD

0.0%

MKT CAP

₹45 Cr

◉ Active Signals

MACDBearish-0.067

RSI(14)Bearish35.13

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VIVIMEDLAB and at what entry.